RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Regulus Therapeutics Inc. (RGLS)
Market is closed
News
- First
- << Previous
- 21 - 26
Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital's Top New Biotech Picks
Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of its top new picks in the...
Alkermes Plc (ALKS), Quest Diagnostics Inc (DGX): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
This Metric Says You Are Smart to Sell Star Scientific, Inc. (STSI)
Star Scientific, Inc. (NASDAQ:STSI) was in 4 hedge funds' portfolio at the end of March. STSI investors should be aware of a decrease in support from the world's most elite money managers lately.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS), Regulus Therapeutics Inc (RGLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
The Coca-Cola Company (KO), Tesla Motors Inc (TSLA) Among Stocks to Sell Near 52-Week Highs
Commodities may be in the midst of a nasty sell-off, and worries about Cyprus' financial ripples continue to persist, yet 2,300 of 4,800 companies in The Motley Fool CAPS Screener database are still within...
- First
- << Previous
- 21 - 26
Billionaire Hedge Funds
